The CEO of Greggs has boldly stated that the surge in popularity of appetite-suppressing medications is undeniably influencing customer behavior, leading to a growing demand for "smaller portions". This shift is having a noticeable impact on the company's financial performance.
As consumers increasingly seek options rich in protein and fiber, along with generally healthier food choices, Roisin Currie emphasized that Greggs is actively adapting its product lineup to meet these changing preferences. The bakery chain has previously acknowledged that shifts in dietary habits have prompted a departure from their traditional offerings of hearty, high-fat pastries, cakes, and other indulgent items.
Currie's insights come at a time when Greggs has reported disappointing profit figures and a cautious outlook for the upcoming year, indicating a broader trend towards health-conscious eating among the public. She remarked that there is an undeniable "broader health trend" taking shape, with customers increasingly demanding higher protein content in their meals.
In response to this evolving market, Greggs announced in July its intention to cater to consumers using weight loss drugs by introducing smaller portion sizes and products high in protein. This strategy included the launch of their egg-pot in conjunction with the popular "eggs at Greggs" advertising campaign, aimed specifically at this audience.
Currie noted that it is essential for the company to offer snack options that align with the preferences of those utilizing GLP-1 medications, which are designed to aid in weight management. Other companies have also observed similar changes in consumer appetites due to the prevalence of weight loss drugs.
For instance, Tesco recently reported that a shift towards healthier eating habits has positively impacted their fresh produce sales. Chief executive Ken Murphy highlighted that the supermarket is closely monitoring consumer trends, particularly in light of the rising use of weight loss medications, and has developed a selection of "GLP-1 friendly" products to accommodate these demands. He affirmed, "Clearly our strongest source of growth this year has been in fresh food, and that is, by far and away, the best thing people can eat."
Additionally, Tesco offers a diverse range of high-protein products across various categories, positioning itself well to adapt to the ongoing trends in healthier eating.
Consumer analyst Clive Black from Shore Capital suggested that the slight decline in grocery volumes sold over the Christmas period compared to the previous year may be one of the clearest indicators of how glucagon-peptide (GLP) drugs are altering national eating habits.
Moreover, the phenomenon of "shrinkflation" is contributing to the move towards smaller portion sizes, as companies reduce the quantity of products while maintaining prices, all in an effort to accommodate financially strained consumers.
Adding to the conversation around healthy eating, a recent UK government ban on junk food advertising before 9pm aims to combat rising obesity rates, reflecting a significant societal shift towards prioritizing health.
